Skip to main content

Find Clinical Trials

Home
Conditions
Oligodendroglioma IDH-1 Mutant and 1/p19q-codeleted

Clinical trial condition

Oligodendroglioma IDH-1 Mutant and 1/p19q-codeleted

Explore clinical trials studying Oligodendroglioma IDH-1 Mutant and 1/p19q-codeleted. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Oligodendroglioma IDH-1 Mutant and 1/p19q-codeleted trial results

Not Yet Recruiting

Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease

NCT07703436

Conditions: Astrocytoma IDH Mutant Grade 2, Astrocytoma IDH Mutant Grade 3, Glioma, +12 more
Locations: Not specified

View Trial Details